Lorenzo Spaggiari

Genomic characterization of asymptomatic CT-detected lung cancers

E. Venturini, G. Pelosi, G. Veronesi, 2011, Oncogene.

Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

G. Pelosi, M. Papotti, D. Galetta, 2013, Endocrine-related cancer.

New and old biomarkers in the differential diagnosis of lung cancer: Pro-gastrin-releasing peptide in comparison with neuron-specific enolase, carcinoembryonic antigen, and CYFRA 21-1

D. Radice, D. Galetta, L. Spaggiari, 2019, The International journal of biological markers.

Red meat, Mediterranean diet and lung cancer risk among heavy smokers in the COSMOS screening study.

G. Veronesi, L. Spaggiari, M. Bellomi, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Computed tomography screening for lung cancer: results of ten years of annual screening and validation of cosmos prediction model.

F. Petrella, G. Veronesi, L. Spaggiari, 2013, Lung cancer.

Long-term effects of inhaled budesonide on screening-detected lung nodules.

B. Bonanni, D. Radice, G. Veronesi, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer

E. Giovannetti, D. Radice, G. Pelosi, 2010, The Pharmacogenomics Journal.